nerdierthany0u-blog

[nerdierthany0u-blog]

Healthcare Automation Market Future and Technological Advancement 2026 | Aetna, Allscripts Healthcare Solutions, Cerner, Cigna Corporation, OptumHealth, Oracle, IBM Corp

Healthcare industry is rapidly adopting new technologies such as Artificial Intelligence (AI), robotics, medical imaging analytics; and extracting maximum benefits to drive down operational efficiencies, reduce cost of care, and enhance quality of care. Healthcare automation applications are assisting healthcare professionals and hospital administrators in conducting daily activities seamlessly and treating and managing patient care more efficiently. For instance, according to an Indiana University data, 2014, doctors using AI for treatment decisions has increased patient outcomes by 50% while health care costs reduced to half. Smart scheduling applications are allowing appointments with nurses on the basis of patient proximity, matching medical specialty to the patient’s need, and then schedules the best-matched nurse to visit the patient at home. Automation provides nurses with detailed real-time patient information with a single interface to offer the best possible care. Request For Customization Of This Research Report: www.coherentmarketinsights.com/insight/request-customizat... Furthermore, automation of information such as patient reports, billing, and prescriptions allow hospital staff instant access to the pertinent information to treat any patient during the entire process. This reduces wait time for patients, improves the facilities to adequately care for patients, and saves time in collecting and maintaining information. Utilization of information technology in treatment and diagnostic processes is expected to accelerate development of clinical, hospital, and health care processes. Healthcare Automation Market Dynamics Advancements in healthcare information technology, increasing geriatric population base, and rising incidence rates of both chronic and acute diseases are expected to increase adoption of automation in the field of healthcare. According to the World health Organization (WHO) 2013 report, increasing elderly population is also rising the incidence of age-related illnesses such as Dementia and Parkinson’s disease worldwide. As a result, there is an increased burden on healthcare and medical resources along with more dependency on families and caregivers. Implementation of automation technology in healthcare facilities can consolidate their staff and reduce expenses. According to the WHO report, the global shortage of healthcare workers was 7.2 million in 2013, and it is expected to reach 12.9 million by 2035. The technology will be able to save current staff members time as well as healthcare facilities. Healthcare Automation Market Regional Insights Regional segmentation of healthcare automation market by Coherent Market Insights include North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America and Europe are expected to hold major share in healthcare automation market, owing to advancements in healthcare and IT facilities. Moreover, increased funding in R&D coupled with automation in healthcare sector is expected to fuel regional market share. For instance, in 2018, healthfinch, a Madison-based healthcare IT company, raised US$ 17 million since 2011, to continue supporting and building its Charlie Practice Automation Platform. Healthcare Automation Market Competitive Landscape Key players operating in the healthcare automation market include Aetna, Inc., Allscripts Healthcare Solutions, Cerner, Cigna Corporation, OptumHealth, Oracle, IBM Corp, Verisk Analytics, MedeAnalytics, McKesson, Truven Health Analytics, and UnitedHealth Group, Inc. Industry players are continuously working towards developing new solutions in order to reduce healthcare costs and completely automate the process. For instance, ibml intelligent capture solutions allow healthcare payers to automate the unstructured data to reduce administrative expenses, enhance customer service, accelerate cycle times, speed audits through improved reporting, and strengthen regulatory compliance, and internal controls. Download The PDF Brochure: www.coherentmarketinsights.com/insight/request-pdf/2033

[nerdierthany0u-blog]

Cancer Vaccines Market to Perceive Substantial Growth During 2018–2026

Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes. On the basis of the type of cell it initiates to form cancerous with, it is divided into carcinoma, lymphomas, leukaemias, brain tumors, and sarcomas. According to World Health Organization (WHO), 2017, nearly 1 in 6 deaths is due to cancer globally and around 70% of deaths from cancer occur in low- and middle-income countries. Moreover, it is projected that for next two decades, 70% of new cases are expected to be diagnosed globally. Advent of cancer vaccines can significantly reduce this numbers and lead a cancer-free life for the global population.

Key players in the global cancer vaccines market include, Astrazeneca Plc. (Medimmune, LLC.), Glaxosmithkline Plc., Merck & Co., Inc., Sanofi Pasteur, Aduro BioTech Inc., Sanpower Group, Astellas Pharma Inc., CSL Limited, Pfizer Inc., and Serum Institute of India Pvt. Ltd.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/1209

According to a research from University of Pittsburgh School of Medicine, in 2017, a high dose flu vaccine can be used to treat people aged between 54–64 years with chronic condition such as heart disease, lung disease, diabetes, and cancer. The study is recommended for clinical trials in geriatric population.

Also, in 2017, Swiss Biotech, developed VXM01 — an attenuated bacterial vaccine modified to express vascular endothelial growth factor receptor-2 (VEGFR2), stimulates cytotoxic (killer) T cells, which will destroy cells in the vasculature feeding tumor and allow greater infiltration of immune cells. This vaccine is expected to be used for treatment in colorectal cancer and glioblastoma.

Click To Read More On Cancer Vaccines Market

[nerdierthany0u-blog]

Industrial Microbiology Market with Latest Technological Advancements Trends, Drivers and Forecast 2026

Applied Microbiology involves use of microorganisms in various industries, such as pharmaceutical and biotechnology industry, cosmetic industry, food and beverages industry, agriculture and environment, and many others. The use of advanced technology and knowledge about microorganisms in healthcare and environmental issues is of prime importance. In case of pharmaceutical industry the products manufactured using microbiology include amino acids, organic acids, vitamins, nucleotides, antibiotics, insulin and other hormones, polysaccharides, bio surfactants, and hormones.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/981

Pharmaceutical microbiological safety, food microbiological safety, cosmetics microbiological safety and contamination control can be assured with the application of microbiology. Application of microorganisms is beneficial as maximum yield of a product can be obtained with the help of customization of the microorganism species such as exposing them to mutagens or by gene amplification. Biomass conversion is another area wherein microorganisms are employed in various processes such as anaerobic digestion, fermentation, pyrolysis, and gasification.

Advances in fields of Recombinant DNA technology, use of microorganisms in treating diseases, rising prevalence of various bacterial, and viral infections globally is expected to boost the growth of industrial microbiology market with respect to pharmaceutical industry. Use of microorganisms in manufacturing various improvised vaccines for existing as well new infectious diseases is supporting the market growth. Cosmetic industry is growing, owing to the factors, such as evolving lifestyles, increasing demand for aesthetic life fulfilled by various offerings from the industry such as color cosmetics and skin care. Furthermore, in cosmetic industry, raw materials need to be thoroughly tested for any microbial contamination before further processing according to the Food & Drug Administration (FDA). These factors are expected to further propel the use of microbiological testing for cosmetic product safety.

Some major players operating in the industrial microbiology market include Merck KGaA, bioMérieux SA, Thermo Fisher Scientific Inc., Eppendorf AG, Bruker, Sartorius AG, QIAGEN

Click To Read More On Global Industrial Microbiology Market

[nerdierthany0u-blog]

Biopreservation Market Taking New Steps to Meet the Challenges With Major Key Companies

Increasing number of government initiatives for research and development is driving growth of the biopreservation market

Human sperm and egg banks, and demand for preservation of new born stem cells is increasing due to growing awareness about long-term benefits of such preservation such as treatment of diseases, including cancer and autism.  Furthermore, increasing adoption of in- house sample storage for further research in hospitals, is in turn increasing growth of the biopreservation market. Increasing number of government initiatives in the form of grants, funds, and contracts to support research activities for the development of various treatments is also expected to boost growth of the market. For Instance, according to the U.K. government policy, 2015, the government is expected to invest US$ 6.8 million in health and research development by 2020.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/748

Increasing healthcare expenditure globally and increasing investment in bio-banks and personalized medicines, are also propelling growth of the biopreservation market. Rising incidence of lifestyle-related diseases, cardiovascular diseases, cancer, and hypertension are other factors driving growth of the biopreservation market. According to World Health Organization (WHO), in 2015, cardiovascular diseases caused 31% deaths of all diseases, and 8.8 million people died due to cancer. However, tissue injury during biopreservation, high cost associated with maintenance of these instruments are major factors hampering growth of the market.

Broad product portfolio of major players is boosting market growth

Key players operating in the market include Biolife solutions, THERMO- FISHER SCIENTIFIC, BioCision LLC, Simport scientific, Cesca Therapeutics, Atlanta biologics, Lifeline scientific, LabVantage solutions, Hamilton Company, and Core dynamics ltd. Major market players expanding their product portfolio particularly related to media, freezers, refrigerators, consumables, to strengthen their presence in the global market.

Click To Read More On Biopreservation Market

[nerdierthany0u-blog]

Surgical Microscopes Market Poised to Achieve Significant Growth in the Years to Come

A surgical microscope is an electrically or mechanically operated optical microscope designed for use in surgical settings for performing microsurgeries. The combination of lenses provide stereoscopic vision, magnification ranging from 4x–40x, and illuminated image of the surgical area. Surgical microscopes is an applied science equipment design intended to maximize productivity by reducing surgical discomfort. Strain-free procedures, easy sterilization or disinfection to avoid cross infection prove to be helpful in increasing the diagnostic efficacy. The innovative modern surgical microscopes can be placed on a table top, worn by the surgeon on the head or mounted on a stand, which enables the surgeon and patient to gain a better view of the target site. The microscope finds its applications in dentistry, gynecology, ophthalmology urology, neurosurgery, spine surgery, oncology, reconstructive surgeries, etc.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/727

Technological innovations such as red reflex stability to play a vital role in boosting surgical microscopes market growth Some of the key players operating in the surgical microscopes market are Carl Zeiss, Novartis AG, Leica Microsystems, and Allition. The acquisition of WaveTec Vision by Alcon had proved to strengthen its product portfolio in the ophthalmic surgical market. Other manufacturers leading the market with strategies such as new product launches, technological innovation, mergers and acquisition are Takagi Corporation, Accu-Scope Inc., Topcon, HAAG-STREIT SURGICAL, and Seiler. Red reflex stability is produced by ophthalmic surgical microscope, which improves illumination for precise visualization and enhanced surgical efficacy.

Click To Read More On Surgical Microscopes Market

[nerdierthany0u-blog]

Interventional Cardiology Devices Market 2018: Competitive Strategies, Pricing Strategy, Target Audience

Interventional cardiology is the branch of cardiology that specifically deals with catheter based treatment of heart diseases, such as congenital heart defect (CHD), coronary artery disease, and aneurysm. This involves insertion of the catheter into femoral artery or any large peripheral artery or vein and through catheter whole procedure is performed by using fluoroscopy. Interventional cardiology has reduced the complications for patients as it provides, fast recovery, short hospital stay, and controlled bleeding. There is constant development in interventional cardiology devices, such as from bare metal stent to bio-absorbable stent. According to Centers for Disease Control and Prevention, which provides information about various diseases, there were around 40,000 children born with CHD in the U.S. in 2016. Interventional cardiology devices include catheters, guide wire, stents, filters, and balloons.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/691

Increased prevalence of cardiovascular diseases is expected to fuel the growth of interventional cardiology devices market There is a continuous increase in geriatric population and obesity which is leading  to the increase in cardiovascular disease. For instance, as per United Nations report, there were around 901 million people of age 60 and above in 2015 and it is expected to reach 1.4 billion by 2050. Advancement in healthcare research, increasing patient awareness, and increase in the demand for minimal invasive surgery raise the demand for interventional cardiology devices. Interventional cardiology devices help interventional cardiologist to perform the procedure in short span of time, which reduces the risk and complication.

Key players to support the interventional cardiology devices market There are various players present across the globe contributing to the interventional cardiology devices market. Some key players are Abbott, Terumo Medical Corporation, Boston Scientific Corporation, Cardinal Health, Medtronic, Cook Medical and B. Braun Melsungen AG. In 2017, Abbott acquired St Jude Medicals to increase the product pipeline, as St Jude Medicals are into atrial fibrillation, structural heart, heart failure and chronic pain and Abbott are leading in coronary inventions, which increase the market share and fuels the growth of interventional cardiology devices market.

Click To Read More On Interventional Cardiology Devices Market

[nerdierthany0u-blog]

Fetal Monitoring Market: Views Sought On New Approach

Fetal monitoring devices are used to monitor the heart rate and movement of the fetus and maternal contractions. In medical terms, fetal monitoring is imperative to constantly monitor health of the unborn baby and ensure a safe birth. Fetal monitoring measures the heart rate of the baby. Healthcare providers perform fetal monitoring during late pregnancy and labor, as that process is crucial for keeping the mother and the child safe and healthy. These are also used to monitor chronic mental retardation, hypothermia, lung diseases, neonatal diseases, vision & hearing problems, and jaundice.

Increase in birth rate fuels the growth of fetal monitoring market

The boost in fetal monitoring market is due to increased rate of birth and pre-term births. Various government and nongovernment organizations are actively taking initiatives to provide better maternal and fetal care. However, rise in number of problems during pregnancy due to high-blood pressure, diabetes, pre-term labor medicine affect the fetus. So, fetal monitoring device are used routinely by gynecology and obstetrics interventions to examine fetal health during labor and delivery.

Download The PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/466

Fetal monitoring is usually done using handheld doppler device or an electronic fetal monitor. Fetal monitoring is necessary to avoid complications during labor or if patient gets an epidural or if oxytocin is required to induce or augment labor. Moreover there are two ways to perform fetal monitoring namely, external and internal. Fetal monitoring is especially helpful if the patient is expected to have a high-risk pregnancy, especially women suffering from high blood pressure or diabetes.

Moreover, rising investment of company for development of new features for fetal monitoring devices expects to increase the working efficiency of company and broadens its product portfolio. Key players in the fetal monitoring market include ArjoHuntleigh, Inc. (U.S.), C FUJIFILM SonoSite, Inc. (U.S.), GE Healthcare (U.K.), Natus Medical Incorporated (U.S.), Neoventa Medical (Sweden), ovidien PLC (U.S.), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), Analogic Corporation (U.S.), and Spacelabs Healthcare Inc. (U.S.).

Click To Read More On Fetal Monitoring Market

[nerdierthany0u-blog]

Forensic Technologies and Services Market Report Study, Synthesis and Summation 2018-2026

Advanced technologies in forensics science have been of substantial importance in recent years. Few examples of such advancements include enhanced fingerprint retrieval from metal objects such as gun cartridges and various metal ammunition, role of chemistry to identify the chemical and biological weapons, and integration of various technologies which can improve the detection of various drugs and explosives materials at security checkpoints.

Forensic technology teams use various advanced technological solutions to recover, search, and analyze large complex data sets. A part of the team of forensic experts visits the crime scene to gather evidence while the rest work at the laboratory and perform analysis on various objects or samples obtained at the crime scene. The samples or objects usually considered for criminal evidence usually include fingerprints. Other samples such as hair or pieces of skin can be used for DNA testing, which can help identify various specifics such as gender and age of the subject.

Get A Sample Copy Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/367

Chemicals Analysis: A Fast Emerging Segment

Chemical analysis is a forensic study that has multiple applications in identification of illegal substances within the criminal justice system. The chemicals usually considered are used to examine the way the atoms and molecules in the sample interact and bond with each other. Forensic experts in the lab use these distinguishing features to identify substances using various advanced methods that can be replicated in the lab and thus, are presentable as evidence in court.

Click To Read More On Global Forensic Technologies and Services Market

[nerdierthany0u-blog]

Cystic Fibrosis Market predicts rise in demand by 2026

Over the last few years, advancements in technology have resulted in a shift in research and development towards treatments that target the fundamental cause of the disease by targeting the CFTR function. Moreover, there is an affinity towards licensing the products, and for that reason alliances are being made by a number of biotechnology and pharmaceutical manufacturers, since the majority of the treatments for cystic fibrosis are developed by smaller manufacturers. The increase in licensing activity along with the rise in the number of new partnerships will encourage the smaller companies to continue their research work thereby giving a positive momentum to the cystic fibrosis market.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/236

In spite of significant advancement in cystic fibrosis therapeutics, individuals suffering from CF face significant unmet needs owing to the deficiency of restorative therapies, inadequate choice of mucolytic treatments, and the unvarying fight alongside severe lung infection that needs the expansion of novel antibiotics. These factors are likely to drive the growth of the cystic fibrosis market during the forecast period.

High prevalence of genetic diseases including CF will drive the overall cystic fibrosis market

According to Netwellness, a community service provider, 3 to 4% of the babies are born with genetic disorders. This number is poised to rise in the coming years, especially in the emerging economies of Asia pacific such as China and India owing to high birth rate observed in these regions. As the number of cases of CF rises, so will the demand for CF treatment, thereby augmenting the growth of the overall cystic fibrosis market during the forecast period.

Click To Read More On Cystic Fibrosis Market

[nerdierthany0u-blog]

Biopsy Devices Market Demand and Necessity 2018 to 2026

A biopsy is a sample of tissue taken from the body for in-depth analysis of the sample to reach an effective diagnosis of a condition, wherein conventional diagnostic methods such as x-rays and body scans do not provide any conclusive evidence. Biopsies are usually carried out to detect cancer, though their application is not restricted to it. This procedure is mostly performed by interventional radiologists, cardiologist and surgeons.

There are different kind of biopsies performed for different conditions and usually sharp tools are required to remove small amount of tissues. Listed below are some of the common types of biopsies:

Needle biopsy, CT-guided biopsy, Bone biopsy, Bone marrow biopsy, Ultrasound-guided biopsy, Liver biopsy, Kidney biopsy, Aspiration biopsy, Skin biopsy, Surgical biopsy

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/220

Global Biopsy Devices Market Outlook: Burgeoning growth in incidence rate of cancer fueling demand for preventive tests

High incidence of cancer is one of the main factor responsible for growth of the biopsy devices market. As per statistics released by the World Health Organization (WHO), around 14 million new cases of cancer were reported worldwide in 2012, with incidence rate expected to surge by exponentially by 70% over the following two decades. Furthermore, growing geriatric population characterized by a weak immune system, across the globe and increasing consumer health awareness leading to increasing preventive screening are other factors inadvertently fueling growth of the biopsy device market. Apart from this, stringent regulations posed on the companies in terms of labelling, designing and performance issues, as well as high cost of the devices are the major restrain factors which are hampering market growth. One of the main example of this is regular inspection by the regulatory authorities, in which evaluation of the equipment, records inspection and licensure are checked.

Global biopsy device market is projected to witness steady growth in the foreseeable future, with North America, followed by Europe being the largest revenue contributors collectively accounting for around 70% of the overall market. However, rampant increase in government spending on strengthening the healthcare infrastructure in emerging economies such as India and China, in turn is expected to position Asia Pacific as the fastest growing market for biopsy devices through 2024.

Click To Read More On Biopsy Devices Market

[nerdierthany0u-blog]

Oxygen Therapy Market Business Opportunties and Growth 2018 to 2026

Oxygen therapy is used in hospitals to cure patients suffering from respiratory diseases such as COPD and pneumonia, and also cardiovascular diseases fueling growth of the oxygen therapy market. Oxygen therapy is also used in clinics, rehabilitations centers and home care settings .

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/97

Increasing incidence of COPD and lung disorders drive growth of the oxygen therapy market across the globe

Factors such as high prevalence of respiratory related diseases, growing aging population, and increasing vulnerability of the populace to respiratory conditions are fueling growth of the oxygen therapy market in North America. According to the Center for Diseases Control and Prevention (CDC), around 15.7 million people in the U.S. were diagnosed with COPD in 2013. Other factors driving demand for oxygen therapy include innovation in portable oxygen concentrators, rise in number of untreated sleep apnea cases, favorable reimbursement scenario, growing demand for oxygen filling devices, good medical facilities, and high investment in research and development activities

Global players engaged in the oxygen therapy market

There are several medical device companies, both local player and global ones, engaged in manufacture of oxygen therapy devices. Some of the prominent players are Respironics, Inc. (a Philips company), Fisher & Paykel Healthcare Limited, Teleflex Incorporated, Invacare Corporation, AirSep Corporation, CareFusion Corporation, DeVilbiss Healthcare, MAQUET Holding B.V. & Co. KG, and ResMed, Inc.

Click To Read More On Oxygen Therapy Market

[nerdierthany0u-blog]

Dental Wound Dressings Market Research Study including Growth Factors, New Top Players, Competitive Analysis by regions from 2018 to 2026

Dental wound dressings are small unit of medicaments, which is used in oral or maxillofacial surgery and dentoalveolar surgery to dress wounds, relieve pain, and prevent infection and to promote healing. Postoperative bleeding is major complication after tooth extraction. The dental wound dressings are used to control bleeding and protect the surface of the wound from further injury. It also cleans oral wounds created during dental surgery. The type of dressing used for wound dressing depends on various factors such as the type of injury, the size, location, and severity.

Download The PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2436

Dental Wound Dressings Market Driver

Increasing incidences of dental surgeries and root canal treatments are expected to boost the dental wound dressing market growth. For instance, as per Data from the National Health and Nutrition Examination Survey, for 2015–2016, the prevalence of total caries (untreated and treated) in the U.S. was 45.8% and untreated caries was 13.0% among youth aged 2–19 years. Moreover, in 2017, Capstone Clintonville Dentist surveyed that, around 15 million root canal procedures were performed in the U.S. annually.

Dental Wound Dressings Market Restraints

However, high cost of the dental surgeries is limiting the patient’s inflow in the clinics and it is expected to hamper the dental wound dressing market growth. For instance, in 2014, Canadian Academy of Health Sciences stated that Canadians spend around US$ 12 billion annually on dental services, but six million people annually avoid dentists due to high cost of dental services.

Click To Read More On Dental Wound Dressings Market

[nerdierthany0u-blog]

Nutraceutical Excipient Market Application, Driver, Trends & Forecast 2026

Nutraceuticals are dietary supplements that assist in the treatment and prevention of diseases and enhance the performance of pharmaceutical and food products. Various food structures and their compositions are formed by using nutraceutical excipients that enhance the bioavailability of nutraceuticals containing therapeutic products. The major scope for this market is in food industry. Increasing investment of domestic manufactures is expected to boost growth of the market for nutraceutical excipients.

Get A Sample Copy Of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/2417

The Global Nutraceutical Excipients – Market Dynamics

Nutraceutical excipients have improved functionalities that improve manufacturing processes of pharmaceutical dosage forms. Such benefits of nutraceutical excipients are expected to boost growth of the market. Moreover, increasing geriatric population in economies such as India and China is expected to boost growth of the market.

The Global Nutraceutical Excipients Market– Competitive landscape

Key players operating in the market include, DuPont, P&G Chemicals, Eastman Chemical Corporation, Huntsman Corporation, Kerry Group plc, ABF, Roquette Freres, Ingredion, Meggle, Hilmar Ingredients, JRS Pharma, Sensient, Innophos, Cargill, IMCD, Avantor Performance Materials, Zydus Wellness, BASF SE, Lubrizol Corporation, Colorcon Inc., Finar Limited., and Shin-Etsu Chemical Co., Ltd.

Key players in the market are focused on developing new products to enhance their market share. For instance, in March 2018, JRS PHARMA introduced PROSOLV SMCC (Silicified Microcrystalline Cellulose) in Japan.

Click To Read More On Nutraceutical Excipient Market

[nerdierthany0u-blog]

Blood Screening Market By Current Scenario, Key Vendors, Growth Rate, Drivers, Volume & Forecast Report

A blood screening is the process of laboratory testing for extracting blood prior to blood transfusion. The test is performed to ensure that recipients receive safe blood products. There are various blood screening procedures for donated blood to ensure that blood units are safe. Blood samples collected during donation undergo laboratory screening for Transfusion-Transmissible Infections (TTIs). In screening technique, blood sample is tested for evidence of certain infectious disease pathogens such as hepatitis B and C viruses and human immunodeficiency virus (HIV).

Request For A Sample Copy Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2409

There are different types of assay used for blood screening, which include Immunoassays (IAs) and nucleic acid amplification technology (NAT) assays. Immunoassays (IAs) is further subcategorized into enzyme immunoassays (EIAs), chemiluminescent immunoassays (CLIAs), haemagglutination (HA)/particle agglutination (PA) assays, and rapid/simple single-use assays (rapid tests).

Blood Screening Market- Drivers

Increasing demand for NAT over ELISA (enzyme-linked immunosorbent assay) test due to high sensitivity and specificity for viral nucleic acid is boosting growth of the blood screening market. For instance, in 2018, Grifols received approval from the U.S. Food & Drug Administration (FDA) for two blood screening assays- Procleix Ultrio Elite and Procleix WNV. Both assays run on the fully automated NAT blood screening platform: Procleix Panther system. The Procleix Panther system with these assays helps blood centers to efficiently screen for infectious diseases and eliminates the need of batch processing.

Key Player operating in the blood screening market include Grifols,  F. Hoffmann-La Roche,  Abbott Laboratories, Biomérieux, Bio-Rad Laboratories, Inc., Siemens Healthineers (A Subsidiary of Siemens AG), Ortho Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc., Beckman Coulter (A Subsidiary of Danaher Corporation)  and Becton, Dickinson and Company.

Click To Read More On Blood Screening Market

[nerdierthany0u-blog]

Pen Needles Market to witness major growth in coming years

Pen needles are used to inject medication (most commonly to inject insulin in diabetic patients). Pen needles offer various advantages over conventional needle and syringe device such as they aid in self-administration of the medication and do not require expertise. Pen needles are screwed to injection pens through plastic hub and has the required quantity of medication in it. This gets injected through the pen. There are different sizes of pen needle available depending upon the length and gauge.

Different length available are 4mm, 5mm, 6mm, 8mm, 10 mm, and 12mm. Gauge size decides the thickness of pen needle, higher the gauge number, lesser is the thickness. Various gauges with pen needles are 29G, 30G, 31G and 32G. Most advanced pen needles are ultra-fine needles, which are painless and reaches optimally in subcutaneous layer beneath skin, whereas larger size needles such as 8mm and 12 mm may have risk to reach intramuscular layer beneath skin if not inserted properly.

Request Sample Copy Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1612

Pen Needles Market- Market Dynamics

Rising prevalence of diabetes is one of the major drivers for growth of the pen needles market. According to the International Diabetes Federation’s (IDF) Diabetes Atlas 2017, around 425 million patients were suffering from diabetes worldwide by end of 2017. By 2045, this figure is expected to reach around 629 million.

Competitive Landscape

Some of the key players operating in pen needles market are Novo Nordisk A/S, Becton, Dickinson and Company, Ypsomed AG, UltiMed, Inc., TERUMO CORPORATION, HTL-STREFA, Owen Mumford Ltd., B. Braun Melsungen AG, Allison Medical, Inc., Hindustan Syringes and Medical Devices Ltd., and Artsana S.p.a.

Click To Read More On Pen Needles Market

[nerdierthany0u-blog]

Seasonal Influenza Vaccines Market Key Players, Industry Overview, Supply and Consumption, Demand and forecast to 2026

Influenza is contagious respiratory disease that is caused by influenza viruses and can lead to hospitalization and even death in certain severe cases. Influenza virus infect the respiratory tract (nose, throat, and lungs) in humans. Seasonal influenza detected year-round and the virus is most common during the influenza season especially in fall and winter months.

Some of the key players in the seasonal influenza vaccines market includes Sanofi S.A., CSL Limited, GlaxoSmithKline Plc., and Medimmune, LLC. Key players in the market are involved in strategic mergers and acquisitions, to cater to increasing demand for these vaccines. For instance, in August 2017, Sanofi Pasteur acquired Protein Sciences Corporation, thus adding Flublok products to its portfolio — the only FDA approved recombinant protein-based influenza vaccine. With the acquisition, Sanofi expanded its influenza vaccine portfolio and its presence in the global vaccines market.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/1604

Seasonal Influenza Vaccines Market – Drivers

Increasing incidence of seasonal influenza infection in various geographies is expected to be a major driving factor for growth of global seasonal influenza vaccines market. Rising pandemic events of influenza virus and their severity attributed to the genetic diversity of influenza virus is also another factor aiding in growth of the market. According to the World Health Organization (WHO), 2015, around 233 million outpatient visits, 5.2 million hospital admissions, and 7.4 million deaths are expected if a pandemic case were to occur, globally. Also, the Centers for Medicare & Medicaid Services (CMS) provides reimbursement covering 100% of the costs of one seasonal influenza virus vaccinations per influenza season, and it also covers the seasonal influenza virus vaccinations.

Click To Read More On Seasonal Influenza Vaccines Market

[nerdierthany0u-blog]

Biomarkers Market: Competitive Dynamics & Global Outlook 2026

Biomarkers are used for diagnosis and drug development, as these biomarkers can indicate diseases in the body. Furthermore, biomarkers can be any specific cells, molecules, genes or gene products, enzymes or hormones. Biomarker-based test are precise and rapid, which help in early prediction of susceptibility, prognosis, diagnosis, and treatment of disease. Hence, increasing research and development activities for identifying new biomarkers to diagnose or treat diseases is expected to be major factor growth of the market.

Biomarker are required for personalized medicine as it helps to identify the unique characteristics of the disease and helps to tailor medicine according to the need of patients. Hence, to cater to demand for personalized medicines, pharmaceutical companies are investing in R&D, which is expected to lead to identification of novel biomarkers, thus aiding in growth of the market.

Request Sample Copy Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1530

Key players are involved in new product launches to cater to increasing demand for biomarkers. For instance, in 2016 Abbott Laboratories launched Point-of-Care i-STAT Alinity, an innovative, handheld blood testing platform. Some of the other key players in biomarkers market include Medtronic plc, BG Medicine, Inc., F. Hoffmann-La Roche Ltd., Seimens Healthnineers, Nexus-DX, Qiagen N.V., and Lifesign LLC.

Click To Read More On Biomarkers Market